Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Central Sensitization on Shoulder Steroid Injection Response
NCT05926895Completed
- Sponsor
- Sultan Abdulhamid Han Training and Research Hospital
- Start
- Jun 2023
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of betamethasone dipropionate + betamethasone sodium phosphate in subacromial impingement syndrome (SAIS) (2 arms), sponsored by Sultan Abdulhamid Han Training and Research Hospital. Primary endpoints: Visual Analog Scale at 3 months and Shoulder Range of Motion at 3 months. Started Jun 2023; status: completed.
02
Drugs
betamethasone dipropionate + betamethasone sodium phosphate
03
Conditions
subacromial impingement syndrome (SAIS)
Beyond the preview
Go deeper on NCT05926895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05926895.